The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical Center, New York, NY 10021, USA.
Fertil Steril. 2012 Sep;98(3):671-4. doi: 10.1016/j.fertnstert.2012.05.050. Epub 2012 Jul 4.
To investigate the incidence of negative serum hCG level after initial IM trigger injection and whether such cycles can be salvaged through repeat administration of IM hCG.
Retrospective cohort study.
Academic medical center.
PATIENT(S): All patients undergoing IVF at the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, from January 1, 2005 to November 1, 2011.
INTERVENTION(S): Repeat hCG administration in cases of failed initial trigger.
MAIN OUTCOME MEASURE(S): Fertilization, implantation, clinical pregnancy, and live birth rates were analyzed in the index population compared with a control population matched for age, year of cycle start, diagnosis, stimulation protocol, number of prior IVF attempts, oocyte yield, and number of embryos transferred.
RESULT(S): The incidence of failed initial IM hCG injection was low, occurring in only 0.25% of the 17,298 fresh IVF cycles at our center during the study period. Of the 41 patients undergoing retrieval who received a second IM injection of hCG approximately 24 hours after the first, the live birth rate was 39.02%. Compared with matched controls, there were no statistical differences in oocyte maturity, fertilization, implantation, clinical pregnancy, or live birth rates.
CONCLUSION(S): Although the incidence of failed hCG injection is rare, this study reveals that cycles characterized by incorrect initial administration or failed absorption of hCG can be salvaged by early detection and repeat injection. Assisted reproductive technology (ART) programs may benefit their patients through the assessment of either urine pregnancy tests or measurement of quantitative serum β-hCG levels before retrieval, thereby preventing empty follicle syndrome.
研究初始肌内(IM)触发注射后血清 hCG 水平呈阴性的发生率,以及这些周期是否可以通过重复 IM hCG 给药来挽救。
回顾性队列研究。
学术医疗中心。
2005 年 1 月 1 日至 2011 年 11 月 1 日期间,在威尔康奈尔医学院罗纳德·O·珀尔曼和克劳迪娅·科恩生殖医学中心接受体外受精(IVF)的所有患者。
在初始触发失败的情况下重复给予 hCG。
在索引人群中,与年龄、周期起始年份、诊断、刺激方案、之前 IVF 尝试次数、卵母细胞产量和胚胎移植数量匹配的对照人群相比,受精、种植、临床妊娠和活产率进行了分析。
初始 IM hCG 注射失败的发生率很低,在研究期间我们中心的 17298 个新鲜 IVF 周期中仅发生 0.25%。在接受第二次 IM 注射 hCG 的 41 名患者中,大约在第一次注射后 24 小时,活产率为 39.02%。与匹配的对照组相比,卵母细胞成熟度、受精、种植、临床妊娠或活产率无统计学差异。
尽管 hCG 注射失败的发生率较低,但本研究表明,通过早期发现和重复注射,可以挽救初始给药不正确或 hCG 吸收失败的周期。辅助生殖技术(ART)项目可以通过在取卵前评估尿液妊娠试验或定量血清β-hCG 水平,从而预防空卵泡综合征,使他们的患者受益。